ch.oddb.org 
German | English | French
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "L01EN" (9)Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
Pemigatinib (L01EN02) 6 products WHO-DDD  
L IPCI Pemazyre 4,5 mg14 + 14 + 146644.077124.6010 %Tablets: Pemigatinibum 4.5 mgIncyte Biosciences
International Sàrl
A / SL
L IPCI Pemazyre 9 mg14 + 14 + 146644.077124.6010 %Tablets: Pemigatinibum 9 mgIncyte Biosciences
International Sàrl
A / SL
L IPCI Pemazyre 13,5 mg14 + 14 + 146644.077124.6010 %Tablets: Pemigatinibum 13.5 mgIncyte Biosciences
International Sàrl
A / SL
  IPCI Pemazyre 4,5 mg28k.A.Tablets: Pemigatinibum 4.5 mgIncyte Biosciences
International Sàrl
A
  IPCI Pemazyre 9 mg28k.A.Tablets: Pemigatinibum 9 mgIncyte Biosciences
International Sàrl
A
  IPCI Pemazyre 13,5 mg28k.A.Tablets: Pemigatinibum 13.5 mgIncyte Biosciences
International Sàrl
A
Futibatinib (L01EN04) 3 products WHO-DDD  
L IPCI Lytgobi 4 mg351942.472128.9510 %Coated tablets: Futibatinibum 4 mgTaiho Oncology Europe
GmbH
A / SL
  IPCI Lytgobi 4 mg21k.A.Coated tablets: Futibatinibum 4 mgTaiho Oncology Europe
GmbH
A
  IPCI Lytgobi 4 mg28k.A.Coated tablets: Futibatinibum 4 mgTaiho Oncology Europe
GmbH
A
 show caption
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home